Prognostic Analysis of Thymoma-Associated Myasthenia Gravis (MG) in Chinese Patients and Its Implication of MG Management: Experiences from a Tertiary Hospital

BACKGROUND: Myasthenia gravis (MG) is an autoantibody-mediated neuromuscular disorder. Approximately 10–20% of all MG patients experience thymoma (benign tumor arising from thymus tissue). Thymectomy has been the standard of care for thymomatous myasthenia gravis (TMG). However, the clinical outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Di, Peng, Yuyao, Li, Zhibin, Jin, Wanlin, Zhou, Ran, Li, Yi, Xu, Qiushuang, Yang, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166054/
https://www.ncbi.nlm.nih.gov/pubmed/32341644
http://dx.doi.org/10.2147/NDT.S243519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166054/
https://www.ncbi.nlm.nih.gov/pubmed/32341644
http://dx.doi.org/10.2147/NDT.S243519

Ejemplares similares